2006 - Distinguished Scientist Award, American Heart Association
1976 - Canada Gairdner International Award
William B. Kannel mostly deals with Framingham Heart Study, Internal medicine, Cardiology, Framingham Risk Score and Blood pressure. He combines subjects such as Stroke, Proportional hazards model, Cohort and Risk factor with his study of Framingham Heart Study. In his study, which falls under the umbrella issue of Internal medicine, Cohort study and QRISK is strongly linked to Surgery.
His research integrates issues of Diabetes mellitus and Left ventricular hypertrophy in his study of Cardiology. The concepts of his Framingham Risk Score study are interwoven with issues in Epidemiology, Sudden death, Mortality rate, Blood serum and Physical therapy. William B. Kannel has included themes like Prospective cohort study and Obesity in his Blood pressure study.
Internal medicine, Framingham Heart Study, Cardiology, Framingham Risk Score and Blood pressure are his primary areas of study. His Internal medicine study frequently draws parallels with other fields, such as Endocrinology. His study in Framingham Heart Study is interdisciplinary in nature, drawing from both Epidemiology, Cohort study, Surgery, Incidence and Cohort.
William B. Kannel interconnects Diabetes mellitus and Left ventricular hypertrophy in the investigation of issues within Cardiology. The study incorporates disciplines such as Intermittent claudication, Prospective cohort study, Atrial fibrillation, Physical therapy and Heart disease in addition to Framingham Risk Score. His Blood pressure research includes themes of Body mass index and Obesity.
William B. Kannel mostly deals with Internal medicine, Framingham Heart Study, Cardiology, Framingham Risk Score and Risk factor. His Internal medicine research is multidisciplinary, relying on both Diabetes mellitus and Endocrinology. William B. Kannel has researched Framingham Heart Study in several fields, including Stroke, Epidemiology, Surgery and Cohort study.
His Cardiology study combines topics in areas such as Mortality rate, Proportional hazards model and Left ventricular hypertrophy. As a member of one scientific family, he mostly works in the field of Framingham Risk Score, focusing on Cohort and, on occasion, Offspring and Menopause. The various areas that William B. Kannel examines in his Risk factor study include Absolute risk reduction and Metabolic syndrome.
His main research concerns Framingham Heart Study, Internal medicine, Risk factor, Cardiology and Framingham Risk Score. His Framingham Heart Study study incorporates themes from Epidemiology, Incidence, Surgery, Cohort study and Gerontology. His study brings together the fields of Endocrinology and Internal medicine.
His studies in Risk factor integrate themes in fields like Stroke, Absolute risk reduction and Cohort. His work deals with themes such as Mortality rate and Heart rate, which intersect with Cardiology. His research investigates the connection with Framingham Risk Score and areas like Body mass index which intersect with concerns in Weight loss, Algorithm and Confidence interval.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Prediction of Coronary Heart Disease Using Risk Factor Categories
Peter W. F. Wilson;Ralph B. D’Agostino;Daniel Levy;Albert M. Belanger.
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.
Philip A. Wolf;Robert D. Abbott;William B. Kannel.
High density lipoprotein as a protective factor against coronary heart disease: The Framingham study
Tavia Gordon;William P. Castelli;Marthana C. Hjortland;William B. Kannel.
The American Journal of Medicine (1977)
Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study
Daniel Levy;Robert J. Garrison;Daniel D. Savage;William B. Kannel.
The New England Journal of Medicine (1990)
General Cardiovascular Risk Profile for Use in Primary Care The Framingham Heart Study
Ralph B. D’Agostino;Ramachandran S. Vasan;Michael J. Pencina;Philip A. Wolf.
Diabetes and Cardiovascular Disease: The Framingham Study
William B. Kannel;Daniel L. McGee.
Impact of Atrial Fibrillation on the Risk of Death The Framingham Heart Study
Emelia J. Benjamin;Philip A. Wolf;Ralph B. D’Agostino;Halit Silbershatz.
The Natural History of Congestive Heart Failure: The Framingham Study
Patrick A. McKee;William P. Castelli;Patricia M. McNamara;William B. Kannel.
The New England Journal of Medicine (1971)
Epidemiologic features of chronic atrial fibrillation: the Framingham study.
William B. Kannel;Robert D. Abbott;Daniel D. Savage;Patricia M. McNamara.
The New England Journal of Medicine (1982)
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels: The Framingham Study
William P. Castelli;Robert J. Garrison;Peter W. F. Wilson;Robert D. Abbott.
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: